<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02268799</url>
  </required_header>
  <id_info>
    <org_study_id>RL002</org_study_id>
    <nct_id>NCT02268799</nct_id>
  </id_info>
  <brief_title>High Sensitivity Troponin T Levels Following DC Cardioversion for Atrial Fibrillation / Atrial Flutter</brief_title>
  <official_title>High Sensitivity Troponin T Levels Following Elective External Direct Current Cardioversion for Atrial Fibrillation / Atrial Flutter</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Limerick</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Limerick</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if there is a rise in serum high sensitivity
      troponin T (a marker for heart muscle injury) following a direct current cardioversion (shock
      therapy) used for patients with atrial fibrillation. This will help us determine if direct
      current cardioversion results in damage to the heart muscles in a sufficient amount to cause
      a rise in high sensitivity troponin T.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      High sensitivity Troponin T is a relatively new biomarker that is highly sensitive and
      specific for myocardial injury. Its widespread use has helped in the determination and
      investigation for myocardial ischemia in patients. Previous studies have shown a rise in
      creatine kinase (CK) and the more specific creatine kinase-MB isoenzyme (CKMB) after DC
      cardioversion. Studies on the earlier generation troponin T found that the levels don't rise
      or rise only minimally after DC cardioversion. The high sensitivity troponin T has never been
      studied in the setting of DC cardioversion.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2014</start_date>
  <completion_date type="Actual">August 2015</completion_date>
  <primary_completion_date type="Actual">August 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>High Sensitivity Troponin T levels pre and 6 hours post cardioversion</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Creatine Kinase levels pre and 6 hours post cardioversion</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>B-type Natriuretic Peptide (BNP) levels pre and 6 hours post cardioversion</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neutrophil Gelatinase-associated Lipocalin (NGAL) levels pre and 6 hours post cardioversion</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">101</enrollment>
  <condition>Atrial Fibrillation</condition>
  <condition>Atrial Flutter</condition>
  <arm_group>
    <arm_group_label>DC Cardioversion</arm_group_label>
    <description>Patients undergoing DC cardioversion</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with atrial fibrillation/flutter who attend the Coronary Care Unit of the
        University Hospital Limerick for a pre-organised appointment for direct current external
        cardioversion will be requested to participate in the study
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with atrial fibrillation / atrial flutter attending for direct current
             external cardioversion

          -  Age 18 or older

        Exclusion Criteria:

          -  Myocardial infarction within the last 6 weeks

          -  Coronary artery bypass grafting, percutaneous coronary intervention or any other
             invasive cardiac procedure within the last 6 weeks
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas J Kiernan, MD</last_name>
    <role>Study Chair</role>
    <affiliation>University of Limerick</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital Limerick</name>
      <address>
        <city>Dooradoyle</city>
        <state>Limerick</state>
        <country>Ireland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Ireland</country>
  </location_countries>
  <verification_date>August 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 15, 2014</study_first_submitted>
  <study_first_submitted_qc>October 17, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 20, 2014</study_first_posted>
  <last_update_submitted>August 12, 2015</last_update_submitted>
  <last_update_submitted_qc>August 12, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 13, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Limerick</investigator_affiliation>
    <investigator_full_name>Ronstan Lobo, MB, BMedSc, MRCPI, MRCP(UK)</investigator_full_name>
    <investigator_title>Dr.</investigator_title>
  </responsible_party>
  <keyword>Cardioversion</keyword>
  <keyword>High Sensitivity Troponin T (Hs-Trop T)</keyword>
  <keyword>Brain Natriuretic Peptide (BNP)</keyword>
  <keyword>Neutrophil Gelatinase-associated Lipocalin (NGAL)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
    <mesh_term>Hypersensitivity</mesh_term>
    <mesh_term>Atrial Flutter</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

